Literature DB >> 24349641

Effects of the Arg-Pro and Gly-Gly-Nle Moieties on Melanocortin-1 Receptor Binding Affinities of α-MSH Peptides.

Jianquan Yang1, Liqin Liu1, Yubin Miao2.   

Abstract

The purpose of this study was to examine the effects of the -Arg-Pro-(RP) and -Gly-Gly-Nle- (GGNle) moieties on the melanoma targeting and clearance properties of 99mTc-peptides. We synthesized four new peptides {Ac-GGNle-CCEHdFRWC-NH2, Ac-GGNle-CCEHdFRWCRP-NH2, Ac-CCEHdFRWC-NleGG-NH2 and Ac-CCEHdFRWCRP-NleGG-NH2} and determined their melanocortin-1 (MC1) receptor binding affinities in B16/F1 melanoma cells. Then we further examined the biodistribution properties of 99mTc-Ac-GGNle-CCEHdFRWCRP-NH2 and 99mTc-Ac-CCEHdFRWCRP-NleGG-NH2 in B16/F1 melanoma-bearing C57 mice. Overall, the Arg-Pro motif was critical for retaining low nanomolar MC1 receptor binding affinity. The deletion of the -RP- moiety dramatically reduced the receptor binding affinities of the peptides. The N-terminus was a better position than C-terminus for the -GGNle- moiety in retaining the lower renal and liver uptake. High melanoma uptake coupled with fast urinary clearance of 99mTc-Ac-GGNle-CCEHdFRWCRP-NH2 provided a new insight into the design of new α-melanocyte stimulating hormone (α-MSH) peptides.

Entities:  

Keywords:  99mTc-labeled; alpha-MSH peptide; melanocortin-1 receptor; melanoma

Year:  2013        PMID: 24349641      PMCID: PMC3859464          DOI: 10.1021/ml400309u

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  16 in total

1.  Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.

Authors:  J Chen; Z Cheng; T J Hoffman; S S Jurisson; T P Quinn
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

2.  Influence of the bifunctional chelator on the pharmacokinetic properties of 99mTc(CO)3-labeled cyclic α-melanocyte stimulating hormone analog.

Authors:  Maurício Morais; Bruno L Oliveira; João D G Correia; Maria Cristina Oliveira; Maria Angeles Jiménez; Isabel Santos; Paula D Raposinho
Journal:  J Med Chem       Date:  2013-03-01       Impact factor: 7.446

3.  Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides.

Authors:  Haixun Guo; Jianquan Yang; Fabio Gallazzi; Yubin Miao
Journal:  J Nucl Med       Date:  2011-03-18       Impact factor: 10.057

4.  Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake.

Authors:  Haixun Guo; Jianquan Yang; Fabio Gallazzi; Yubin Miao
Journal:  J Nucl Med       Date:  2010-02-11       Impact factor: 10.057

5.  A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting.

Authors:  Paula D Raposinho; João D G Correia; Susana Alves; Maria F Botelho; Ana C Santos; Isabel Santos
Journal:  Nucl Med Biol       Date:  2007-11-19       Impact factor: 2.408

6.  Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.

Authors:  Haixun Guo; Nalini Shenoy; Benjamin M Gershman; Jianquan Yang; Larry A Sklar; Yubin Miao
Journal:  Nucl Med Biol       Date:  2009-04       Impact factor: 2.408

7.  Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.

Authors:  Haixun Guo; Jianquan Yang; Fabio Gallazzi; Eric R Prossnitz; Larry A Sklar; Yubin Miao
Journal:  Bioconjug Chem       Date:  2009-11       Impact factor: 4.774

8.  111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.

Authors:  Yubin Miao; Fabio Gallazzi; Haixun Guo; Thomas P Quinn
Journal:  Bioconjug Chem       Date:  2008-01-16       Impact factor: 4.774

9.  Gallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging.

Authors:  Haixun Guo; Jianquan Yang; Nalini Shenoy; Yubin Miao
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

10.  Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties.

Authors:  Paula D Raposinho; Catarina Xavier; João D G Correia; Soraia Falcão; Paula Gomes; Isabel Santos
Journal:  J Biol Inorg Chem       Date:  2008-01-08       Impact factor: 3.358

View more
  1 in total

Review 1.  New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.

Authors:  Anna Lucia Tornesello; Luigi Buonaguro; Maria Lina Tornesello; Franco Maria Buonaguro
Journal:  Molecules       Date:  2017-08-02       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.